Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against <i>Neisseria gonorrhoeae</i> during murine vaginal infection.

mSphere · 2025 · PMC12108064 · PMID 40237483

Europe PMC DOI

hedged sentence

0.0504

closest p · 1.0× alpha

0.0504

boldest claim

The sentences

approaching significanceP = 0.0504so close (0.05 < p ≤ 0.1)

4CMenB vaccinated animals, 4CMenB stimulation) were approaching significance ( P = 0.0504; Fig.

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against &lt;i&gt;Neisseria gonorrhoeae&lt;/i&gt; during murine vaginal infection.

The sentences

Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against <i>Neisseria gonorrhoeae</i> during murine vaginal infection.